U.S. Diversified Financial Stock News

Kornit Digital (NasdaqGS:KRNT) opened Q1 2026 with revenue of US$48.5 million and a basic EPS loss of US$0.19, alongside a quarterly net loss of US$8.2 million, setting a cautious tone for the latest update. Over recent periods the company has seen revenue move from US$60.7 million in Q4 2024 to US$58.9 million in Q4 2025 and then to US$48.5 million in Q1 2026. EPS has swung between a profit of US$0.05 and losses such as US$0.17 and US$0.19, which keeps the spotlight firmly on margin pressure...

In early May 2026, Vicor reported strong first-quarter results tied to AI and data‑center power demand, while multiple executives and directors exercised stock options and sold shares, alongside JPMorgan disclosing a 6.2% passive stake. The combination of robust AI‑related momentum and heavy insider selling, with no insider purchases over the past year, is sharpening investor focus on how management views Vicor’s current valuation and risk‑reward balance. Against this backdrop of strong AI...

Amentum Holdings (AMTM) has released its Q2 2026 results with revenue of US$3.5b and net income of US$54m, translating to basic EPS of US$0.22 for the quarter and trailing twelve month EPS of US$0.61. The company has seen quarterly revenue move between US$3.2b and US$3.9b over the past six reported periods, while quarterly basic EPS has ranged from US$0.02 to US$0.22. This sets up a picture of modest top line progress paired with gradually improving earnings power. For investors, the key...

Enanta Pharmaceuticals (ENTA) has just posted Q2 2026 results with revenue of US$17.2 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$69.2 million and a basic EPS loss of US$2.47. Over recent quarters the company has seen revenue move between US$14.9 million and US$18.6 million, with quarterly basic EPS losses ranging from roughly US$0.41 to US$1.06 and trailing twelve month net losses of US$62.0 million. For investors, the story this quarter is...

In the first quarter of 2026, COMPASS Pathways reported net income of US$91.2 million, or US$0.71 per share, and announced U.S. FDA acceptance of a rolling New Drug Application and a National Priority Review Voucher for its COMP360 psilocybin therapy in treatment-resistant depression. This combination of an accounting-driven swing to profitability and accelerated regulatory review for COMP360 marks a key moment for COMPASS Pathways’ shift from pure R&D focus toward potential commercial...

Stock performance and business profile International Business Machines (IBM) has delivered mixed share performance recently, with the stock up about 91% over the past 3 years but down 25% year to date and 16% over the past year. At a recent close of US$218.37 and a market value of about US$201.7b, IBM sits among the larger US technology and services companies. It combines software, consulting, infrastructure and financing under one umbrella. The company reports annual revenue of US$68.9b and...

VEON (NasdaqGS:VEON) has opened 2026 with Q1 numbers that put the focus squarely on earnings quality, reporting US$1.2 billion in revenue and basic EPS of US$1.42, while trailing twelve month EPS sits at US$7.65 on revenue of US$4.6 billion. Over recent quarters the company has seen revenue move from US$998 million in Q4 2024 to US$1.03 billion in Q1 2025, US$1.09 billion in Q2 2025 and US$1.20 billion in Q1 2026, with quarterly EPS ranging from a loss of US$2.00 in Q3 2025 to US$8.50 in Q2...

Why EnerSys is back in focus after its latest growth update EnerSys (ENS) has drawn fresh attention after outlining plans to expand in data centers and defense, including reallocating manufacturing capacity and steering its Greenville lithium facility toward drones and soldier power systems. See our latest analysis for EnerSys. The recent communications on AI infrastructure and defense electrification sit alongside very strong momentum, with a 30 day share price return of 20.45%, a year to...

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...

Perella Weinberg Partners recently reported first-quarter 2026 results showing net income of US$1.49 million, down sharply from US$17.34 million a year earlier, while also affirming a quarterly dividend of US$0.07 per Class A share payable in June. Alongside the weaker quarter, the firm expanded Chief Financial Officer Alexandra Gottschalk’s remit to include Chief Operating Officer, highlighting a tighter focus on operational execution as management cited longer timelines to complete complex...

Hasbro’s Q1 2026 earnings in focus Hasbro (HAS) opened 2026 with Q1 revenue of US$1,000.2 million and basic EPS of US$1.41, setting a clear snapshot of the business against a current share price of US$95.65. Over recent quarters the company has seen revenue move from US$887.1 million in Q1 2025 to US$1,000.2 million in Q1 2026, while basic EPS shifted from US$0.71 to US$1.41 over the same period. This gives investors a clearer look at how the top line and per share earnings are tracking. With...

Lineage Cell Therapeutics (LCTX) opened 2026 with Q1 revenue of US$1.7 million and a basic EPS loss of US$0.02, as net income excluding extraordinary items came in at a loss of US$4.8 million. The company has seen quarterly revenue move between US$1.5 million and US$6.6 million over the past year, while EPS has ranged from a loss of around US$0.13 per share to a small profit of US$0.00 per share, presenting a mixed picture regarding the path toward better margins. For investors, the latest...

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...

National Vision Holdings (EYE) opened 2026 with Q1 revenue of US$543.9 million and basic EPS of US$0.39, setting a clear marker for its latest quarter of trading. Over the past year, the company has seen trailing twelve month revenue reach about US$2.0 billion with basic EPS of US$0.59, compared with the prior trailing period’s revenue of US$1.99 billion and EPS of US$0.37. This gives investors a fuller view of how top line scale and per share profitability currently line up. Taken together,...

USA Compression Partners, LP has already reported first-quarter 2026 results, with sales rising to US$309.4 million and net income to US$38.34 million, alongside basic and diluted earnings of US$0.27 per unit from continuing operations. An interesting aspect of the quarter was the very small US$4,000 non-cash impairment charge, sharply lower than the prior year’s US$3.65 million, which highlights a reduced need to mark down long-lived assets. Now we’ll examine how this strong revenue growth...

Capital raising moves put GH Research in focus GH Research (GHRS) has filed a universal shelf registration of up to US$400 million across multiple securities, alongside a US$200 million at-the-market follow-on equity program for its ordinary shares. See our latest analysis for GH Research. The capital raising plans come after a strong run, with the share price at US$21.88 and a 30 day share price return of 33.9%. The 1 year total shareholder return of 119.24% and 3 year total shareholder...

What IRADIMED’s latest dividend and guidance mean for shareholders IRADIMED (IRMD) has drawn fresh attention after reporting first quarter results, reaffirming its 2026 earnings outlook, and declaring a regular quarterly dividend of $0.20 per share payable on May 29, 2026. See our latest analysis for IRADIMED. IRADIMED’s latest results and dividend decision have arrived as the share price has eased in recent months, with a 30 day share price return of 7.13% down and a 90 day return of 12.94%...

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...

SentinelOne (S) is back in focus after launching its Wayfinder Frontier AI Services, even as investors weigh this product expansion against ongoing concerns about margins, profitability, and tough competition from CrowdStrike. See our latest analysis for SentinelOne. At a share price of $16.51, SentinelOne has seen a 29.49% 30 day share price return and a 19.03% 90 day share price return, yet the 1 year total shareholder return is down 17.94%. This suggests recent momentum has picked up even...

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...

Hawkins (HWKN) has wrapped up FY 2026 with fourth quarter revenue of US$265.9 million and basic EPS of US$0.75, rounding out a trailing twelve month run of US$1.08 billion in revenue and EPS of US$3.93. Over the past six quarters, revenue has moved from US$245.3 million in Q4 FY 2025 to US$265.9 million in Q4 FY 2026, while quarterly EPS has ranged between US$0.69 and US$1.41. This gives investors a clear view of how the top line and per share earnings have tracked into the latest print. With...

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...

If you are wondering whether CF Industries Holdings at US$122.97 is still offering value after its run, the next sections walk through what the current price may be baking in. The stock has returned 3.6% over the last 7 days, 3.4% over the past month, 53.5% year to date and 45.1% over the last year, so recent performance is front of mind for many investors assessing what comes next. Recent news coverage has focused on CF Industries Holdings as a key player in the fertilizers and chemicals...

CareTrust REIT (CTRE) raised its 2026 earnings guidance and shared first quarter results that showed higher revenue and net income, giving investors fresh data on how the healthcare focused landlord is currently performing. See our latest analysis for CareTrust REIT. The stock has gained 15.48% year to date on a share price basis to $41.93, while the 1 year total shareholder return of 52.47% and 3 year total shareholder return above 7x suggest momentum has been strong over multiple...